IBDEI2N4 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44312,0)
 ;;=I35.9^^200^2227^8
 ;;^UTILITY(U,$J,358.3,44312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44312,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,44312,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,44312,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,44313,0)
 ;;=I38.^^200^2227^4
 ;;^UTILITY(U,$J,358.3,44313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44313,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,44313,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,44313,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,44314,0)
 ;;=I05.0^^200^2227^18
 ;;^UTILITY(U,$J,358.3,44314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44314,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,44314,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,44314,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,44315,0)
 ;;=I05.8^^200^2227^19
 ;;^UTILITY(U,$J,358.3,44315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44315,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,44315,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,44315,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,44316,0)
 ;;=I05.9^^200^2227^20
 ;;^UTILITY(U,$J,358.3,44316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44316,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,44316,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,44316,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,44317,0)
 ;;=I07.1^^200^2227^21
 ;;^UTILITY(U,$J,358.3,44317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44317,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,44317,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,44317,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,44318,0)
 ;;=I07.9^^200^2227^22
 ;;^UTILITY(U,$J,358.3,44318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44318,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,44318,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,44318,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,44319,0)
 ;;=I08.0^^200^2227^16
 ;;^UTILITY(U,$J,358.3,44319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44319,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,44319,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,44319,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,44320,0)
 ;;=I09.89^^200^2227^17
 ;;^UTILITY(U,$J,358.3,44320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44320,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,44320,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,44320,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,44321,0)
 ;;=I47.1^^200^2227^24
 ;;^UTILITY(U,$J,358.3,44321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44321,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,44321,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,44321,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,44322,0)
 ;;=I48.0^^200^2227^15
 ;;^UTILITY(U,$J,358.3,44322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44322,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,44322,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,44322,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,44323,0)
 ;;=I49.5^^200^2227^23
 ;;^UTILITY(U,$J,358.3,44323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44323,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,44323,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,44323,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,44324,0)
 ;;=I49.8^^200^2227^3
 ;;^UTILITY(U,$J,358.3,44324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44324,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,44324,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,44324,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,44325,0)
 ;;=I49.9^^200^2227^2
